Moberg Pharma AB (MB8.MU)
Munich - Munich Delayed price. Currency in EUR
Add to watchlist
As of 08:00AM CEST. Market open.
| Previous close | 2.3640 |
| Open | 2.2220 |
| Bid | 2.0660 x N/A |
| Ask | 2.1680 x N/A |
| Day's range | 2.2220 - 2.2220 |
| 52-week range | 0.3082 - 3.3380 |
| Volume | |
| Avg. volume | 127 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 13 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireMOB-015 is launched in Sweden under the brand name Terclara- pharmacies report major demand for the new medication
Moberg Pharma ABs (OMX: MOB) marker partner in Sweden - Allderma AB, a company which specialises in the sale of over-the-counter (OTC) pharmaceuticals - has now launched sales of MOB-015 under the Terclara® brand. The interest among pharmacies has been significant for Moberg Pharma's medication against nail fungus.
© 2024 Yahoo. All rights reserved.